Illumina stock forecast.

Dec 1, 2023 · Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus rating of Hold and a price target of $217.47, up 99.1% from its current price of $109.22. See the latest news, analysis, and earnings reports for Illumina on MarketBeat. Jun 12, 2021 · Current Price. $101.57. Price as of November 29, 2023, 4:00 p.m. ET. Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track? In 2016, Cathie Wood and ARK investment ... Jan 13, 2023 · Illumina stock (NASDAQ: ILMN) saw a significant 53% fall in the last twelve months, underperforming the broader S&P500 index, down 16%. ... but an earnings forecast of $1.25 to $1.50 on a per ... Feb 8, 2023 · For the year, Illumina expects core sales to climb 6%-9% and for Grail revenue to be in the range of $90 million to $110 million. ILMN stock analysts called for $4.97 billion in sales, which would ... Shares of ILMN opened at $109.79 on Monday. Illumina, Inc. has a 1-year low of $89.00 and a 1-year high of $238.55. The stock has a market cap of $17.43 billion, a PE ratio of -15.42, a P/E/G ...

Shares of Illumina stock traded up $5.41 on Monday, reaching $115.20. The stock had a trading volume of 1,341,160 shares, compared to its average volume of 1,663,792. The business’s 50-day ...GRAIL stockholders excluding Illumina will receive approximately 9.9 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is above $399 and approximately 13.4 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 ...Following the FTC Chief Administrative Law Judge's (ALJ) decision in favor of Illumina in September 2022, Illumina believes that it has a strong case on appeal. Illumina will move as quickly as possible and seeks to arrive at a resolution in the US Court of Appeals by late 2023 or early 2024, at approximately the same time as the decision in ...

Nov 29, 2023 · According to the issued ratings of 17 analysts in the last year, the consensus rating for Illumina stock is Hold based on the current 3 sell ratings, 7 hold ratings and 7 buy ratings for ILMN. The average twelve-month price prediction for Illumina is $194.56 with a high price target of $328.00 and a low price target of $100.00. Illumina shareholders re-elect eight of nine Illumina directors. SAN DIEGO, May 25, 2023 /PRNewswire/ -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 Annual Meeting, Illumina shareholders have voted to elect eight of …

THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged …The all-time high Illumina stock closing price was 524.84 on August 16, 2021. The Illumina 52-week high stock price is 238.55, which is 117.3% above the current ...Oct 25, 2023 · In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Illumina shares. Our integrated forecast predicts a peak price of $117.68 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. Key statistics. On Monday, Illumina Inc (ILMN:NSQ) closed at 94.65, 6.35% above its 52-week low of 89.00, set on Nov 10, 2023. Data delayed at least 15 minutes, as of Nov 27 2023 21:00 GMT. Latest Illumina Inc (ILMN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Jan 10, 2023 · Illumina stock plunged to its lowest point in three months Tuesday after the gene-sequencing giant issued a disappointing outlook for 2023. ... The company also forecast adjusted earnings of $1.25 ...

Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business.

Mar 20, 2023 · Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response to Carl Icahn's public statements and letters to Illumina's ...

The Motley Fool has premium stock recommendation and portfolio management services with different goals: dividend, growth, value, retirement, income, preservation & options strategies.Oct 15, 2020 · The Illumina stock forecast is 347.82019291099 USD for 2024 November 29, Friday; and 1992.926 USD for 2028 November 29, Wednesday with technical analysis. Illumina (ILMN) stock price prediction is 347.82019291099 USD. Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022. August 11, 2022. Revenue of $1.16 billion for Q2 2022, up 3% from Q2 2021, and up 5% on a constant currency basis. GAAP diluted loss per share of $ (3.40) for Q2 2022, compared to GAAP diluted earnings per share of $1.26 for Q2 2021; GAAP diluted loss per share for …The latest Illumina stock prices, stock quotes, news, and ILMN history to help you invest and trade smarter. ... The 54 analysts offering price forecasts for Illumina have a median target of 255. ...Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, …

Illumina Inc. share price in real-time (927079 / US4523271090), charts and analyses, news, key data, turnovers, company data.🚀 Illumina stock price forecast: $225; Market Cap: 16.91B, Enterprise value: N/A, P/E: -8.16, PEG ratio: 0.01, EPS: -26.66, Revenue: 4.46B, EBITDA: 3.93B, Income ...Q4 2023 EPS Estimate Trends. Current. $0.25. 1 Month Ago. $0.27. 3 Months Ago. $0.72. Illumina Inc. analyst estimates, including ILMN earnings per share estimates and analyst recommendations. Oct 16, 2023 · In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ... Illumina cuts profit outlook as technology chief departs Jamie Smyth in New York Illumina has cut its full-year profit forecast for 2023 citing weak demand from customers and a more protracted ...Shares of Illumina Inc. dropped as much as 7% in late trading after the company cut its sales and profit outlook and said a pair of top executives are departing. The DNA-sequencing company now ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the …

Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions ... Performance Outlook. Short Term. 2W - 6W. Mid Term. 6W - …Aug 6, 2021 · In the first quarter, Illumina’s s ales soared about 27% year-over-year to a record $1 billion, up from roughly 20% YOY during the previous quarter. What’s more, Illumina was profitable ... Illumina is Grail's largest shareholder, holding a 14.5% stake. Grail stockholders, including Illumina, will receive $3.5 billion in cash and $4.5 billion in shares of Illumina stock, the ...Shares of Illumina Inc. slid 6.6% after hours on Wednesday after the DNA-sequencing company tempered its full-year sales outlook, amid a cautious consumer backdrop and a wobbly economic recovery ...Illumina Share Price Live Today:Get the Live stock price of ILMN Inc., and quote, performance, latest news to help you with stock trading and investing.GRAIL stockholders excluding Illumina will receive approximately 9.9 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is above $399 and approximately 13.4 million Illumina shares if the 20-trading-day volume weighted average price of Illumina stock as of 10 ...Oct 25, 2023 · In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Illumina shares. Our integrated forecast predicts a peak price of $117.68 in the forthcoming 30 days, indicating the zenith of the stock's potential performance.

Illumina (ILMN 0.51%) stock has been a huge winner, running up 2,400% over its 21-year history. Will the stock continue to double again, and again, and again?

Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions ... Performance Outlook. Short Term. 2W - 6W. Mid Term. 6W - …

We would like to show you a description here but the site won’t allow us.Aug 6, 2021 · In the first quarter, Illumina’s s ales soared about 27% year-over-year to a record $1 billion, up from roughly 20% YOY during the previous quarter. What’s more, Illumina was profitable ... Illumina’s revenue rising 33% to $4.7 billion over the last twelve months, compared to $3.5 billion in 2019. Our dashboard on Why Illumina Stock Moved has more details. Illumina’s sales have ...Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.ILMN | Complete Illumina Inc. stock news by MarketWatch. ... Illumina Shares Drop on Forecast for 2023 Sales Decline, Wider Loss Nov. 10, 2023 at 8:56 a.m. ET. Stocks to …Shares of Illumina Inc. dropped as much as 7% in late trading after the company cut its sales and profit outlook and said a pair of top executives are departing. The DNA-sequencing company now ...Illumina's board named Jacob Thaysen the new CEO of the DNA sequencing company. Thaysen, a 48-year-old longtime executive at medical devices firm Agilent, will step in as CEO on Sept. 25.We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Oct 16, 2023 · In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ...

ILMN | Complete Illumina Inc. stock news by MarketWatch. ... Illumina Shares Drop on Forecast for 2023 Sales Decline, Wider Loss Nov. 10, 2023 at 8:56 a.m. ET. Stocks to …13 ene 2023 ... Recently, the company provided a frail outlook for 2023, with sales expected to be between $4.90 and $5.03 billion, aligning with the consensus ...When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.🚀 Illumina stock price forecast: $225; Market Cap: 16.91B, Enterprise value: N/A, P/E: -8.16, PEG ratio: 0.01, EPS: -26.66, Revenue: 4.46B, EBITDA: 3.93B, Income ... Instagram:https://instagram. asics stockfederal realty stockhow do i sell sharesdividend payment calculator https://www.illumina.com. Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells ... russell 200robert half layoffs Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.SPX. +0.49%. Shares of Illumina Inc. ILMN, +0.32% tumbled about 10% in premarket trading on Tuesday, the day after the company said it expects lower-than-expected earnings per share of of $1.25 to ... hartford stocks As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Illumina Stock Forecast Over the next 52 weeks, Illumina has on average historically risen by 25.1% based on the past 23 years of stock performance. Illumina has risen higher in 14 of those 23 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.87%